Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Adaptive care for Chinese cancer survivors with insomnia

Official title: Dream2Heal: A Pilot Sequential Multiple Assignment Randomized Trial (SMART) of an Adaptive Stepped-care Intervention for Chinese Cancer Survivors With Mild-to-moderate Insomnia

Run by The University of Hong Kong · NCT06813235 · Data updated 2026-11-12

This study is testing whether a web-based therapy for insomnia or an online exercise program can help Chinese cancer survivors sleep better, and if those who still have trouble can benefit from more intensive face-to-face support.

More Sleep Disturbance trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment72 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedFebruary 2, 2027
Study endsFebruary 2, 2027
Registry record updatedAugust 13, 2026
Trial IDNCT06813235 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include Cantonese- or Mandarin-speaking Chinese patients diagnosed with curable breast, colorectal, or gynecological cancer who have completed treatment within the last two years and exhibit mild-to-moderate sleep disturbances.

Probably not a fit

Patients with metastatic cancer, current psychiatric disorders, other sleep disorders, or those who have received psychological treatment specifically for sleep disturbances may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study aims to evaluate an adaptive stepped-care intervention designed to improve sleep quality among Chinese cancer survivors experiencing mild-to-moderate insomnia. The approach involves comparing a low-intensity web-based cognitive behavioral therapy for insomnia (iDream2Heal) with a web-based exercise intervention (Easy Exercise). Additionally, for those who continue to experience sleep disturbances, a more intensive face-to-face therapist-led intervention will be tested against a combined web-based approach. The study employs a sequential multiple assessment randomized controlled trial (SMART) design to assess feasibility, acceptability, and potential clinical significance.

Why it matters

Potential benefit: If successful, this intervention could significantly enhance sleep quality and overall well-being for cancer survivors dealing with insomnia.

How similar studies have gone: Other studies have shown promise in using cognitive behavioral therapy for insomnia among cancer survivors, suggesting potential success for this adaptive approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Cantonese- or Mandarin-speaking Chinese patients diagnosed with curable breast, colorectal, or gynaecological cancer
* Completed treatment (except endocrine therapy) within two years
* Presenting with Pittsburgh Sleep Quality Index (PSQI) score of 6 to 11 indicating mild-to-moderate sleep disturbance

Exclusion Criteria:

* Diagnosis of metastatic cancer
* Current diagnosis of psychiatric disorder
* Current diagnosis of another sleep disorder,
* Have received psychological treatment specifically for sleep disturbance

Where it's running

  • QMH department of surgery
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Wendy Wing Tak Lam, PhD — School of Public Health, The University of Hong Kong
  • Study coordinator: Danielle Wing Lam Ng, PhD
  • Email: dwlng@hku.hk
  • Phone: +852 39179897

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.